首页|开颅血肿消除术联合安宫牛黄丸治疗重症脑出血的疗效及对患者认知功能的影响

开颅血肿消除术联合安宫牛黄丸治疗重症脑出血的疗效及对患者认知功能的影响

扫码查看
目的 探究临床将开颅血肿消除术联合安宫牛黄丸应用于重症脑出血治疗中的效果,并观察对患者认知功能的影响.方法 筛选 63 例重症脑出血患者,应用随机表法分成对照组(30 例)和观察组(33 例).对照组采用开颅血肿消除术治疗,观察组在对照组基础上联合安宫牛黄丸治疗.比较两组临床疗效及治疗前后脑血流动力学指标(脑血管临界力、平均血流速度、平均血流量)、神经元因子[神经元特异性烯醇化酶(NSE)、S100 钙化蛋白β(S100β)]、神经功能[改良Rankin量表(mRS)评分]、认知功能[蒙特利尔认知评估量表(MoCA)评分].结果 观察组治疗总有效率为 93.94%,较对照组的 73.33%高(P<0.05).治疗后,观察组脑血管临界力(9.60±1.27)kPa低于对照组的(10.38±1.52)kPa,血流速度(97.42±1.39)cm/s、血流量(14.95±4.30)ml/s高于对照组的(86.54±1.60)cm/s、(12.07±4.23)ml/s(P<0.05).治疗后,观察组血清NSE(15.26±1.63)ng/ml、S100β(0.96±0.27)μg/L低于对照组的(18.78±2.34)ng/ml、(1.18±0.31)μg/L(P<0.05).治疗后,观察组mRS评分(2.17±0.15)分低于对照组的(2.91±0.26)分(P<0.05).治疗后,观察组MoCA评分(19.56±2.87)分高于对照组的(16.71±3.15)分(P<0.05).结论 临床将开颅血肿消除术联合安宫牛黄丸应用于重症脑出血治疗中方法可行,其能够提高临床疗效,改善脑血流动力学,调节神经元因子,使患者神经功能及认知功能逐渐恢复.
Effect of craniotomy hematoma removal combined with Angong Niuhuang pill in the treatment of severe cerebral hemorrhage and its influence on cognitive function
Objective To explore the effect of craniotomy hematoma removal combined with Angong Niuhuang pill in the treatment of severe cerebral hemorrhage and observe its influence on cognitive function of patients.Methods 63 patients with severe cerebral hemorrhage were selected and divided into a control group(30 cases)and an observation group(33 cases)by random table method.The control group was treated with craniotomy hematoma removal,and the observation group was treated with Angong Niuhuang pill.Both groups were compared in terms of clinical efficacy,cerebral hemodynamic parameters(cerebral critical force,mean blood flow velocity,mean blood flow),neuronal factors[neuron specific enolase(NSE),S100β],neural function[modified Rankin scale(mRS)score]and cognitive function[Montreal cognitive assessment scale(MoCA)score]before and after treatment.Results The total effective rate of treatment in the observation group was 93.94%,which was higher than 73.33% in the control group(P<0.05).After treatment,the cerebrovascular critical force of(9.60±1.27)kPa in the observation group was lower than(10.38±1.52)kPa in the control group;the observation group had blood flow velocity of(97.42±1.39)cm/s and blood flow of(14.95±4.30)ml/s,which were higher than(86.54±1.60)cm/s and(12.07±4.23)ml/s in the control group(P<0.05).After treatment,the observation group had serum NSE of(15.26±1.63)ng/ml and S100β of(0.96±0.27)μg/L,which were lower than(18.78±2.34)ng/ml and(1.18±0.31)μg/L in the control group(P<0.05).After treatment,the mRS score of(2.17±0.15)points in the observation group was lower than(2.91±0.26)points in the control group(P<0.05).After treatment,the MoCA score of(19.56±2.87)points in the observation group was higher than(16.71±3.15)points in the control group(P<0.05).Conclusion Clinical application of craniotomy hematoma removal combined with Angong Niuhuang pill in the treatment of severe cerebral hemorrhage is feasible,which can improve clinical efficacy,improve cerebral hemodynamics,regulate neuronal factors,and gradually restore the neurological and cognitive functions of patients.

Craniotomy hematoma removalAngong Niuhuang pillSevere cerebral hemorrhageCognitive function

石先辉

展开 >

250300 济南市长清区人民医院

开颅血肿消除术 安宫牛黄丸 重症脑出血 认知功能

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(18)